BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11697510)

  • 1. 2'-Deoxycoformycin for hepatosplenic gammadelta T-cell lymphoma.
    Grigg AP
    Leuk Lymphoma; 2001 Aug; 42(4):797-9. PubMed ID: 11697510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatosplenic T cell lymphoma responsive to 2'-deoxycoformycin therapy.
    Bennett M; Matutes E; Gaulard P
    Am J Hematol; 2010 Sep; 85(9):727-9. PubMed ID: 20652973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentostatin (2'-deoxycoformycin) for the treatment of hepatosplenic gammadelta T-cell lymphomas.
    Corazzelli G; Capobianco G; Russo F; Frigeri F; Aldinucci D; Pinto A
    Haematologica; 2005 Mar; 90(3):ECR14. PubMed ID: 15753055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo effects of 2'-deoxycoformycin (Pentostatin) on tumour cells from human gammadelta+ T-cell malignancies.
    Aldinucci D; Poletto D; Zagonel V; Rupolo M; Degan M; Nanni P; Gattei V; Pinto A
    Br J Haematol; 2000 Jul; 110(1):188-96. PubMed ID: 10930997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatosplenic gammadelta T-cell lymphoma: complete response induced by treatment with pentostatin.
    Iannitto E; Barbera V; Quintini G; Cirrincione S; Leone M
    Br J Haematol; 2002 Jun; 117(4):995-6. PubMed ID: 12060145
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytotoxic T-lymphocyte differentiation and cytogenetic alterations in gammadelta hepatosplenic T-cell lymphoma and posttransplant lymphoproliferative disorders.
    Salhany KE; Feldman M; Peritt D; Nowell PC
    Blood; 1997 May; 89(9):3490-1. PubMed ID: 9129060
    [No Abstract]   [Full Text] [Related]  

  • 7. DNA methylation profile of a hepatosplenic gamma/delta T-cell lymphoma patient associated with response to interferon-α therapy.
    Bhat J; Bergmann AK; Waschina S; Nerl C; Kaleta C; Siebert R; Ammerpohl O; Kabelitz D
    Cell Mol Immunol; 2021 May; 18(5):1332-1335. PubMed ID: 32820235
    [No Abstract]   [Full Text] [Related]  

  • 8. Allogeneic bone marrow transplantation for chemotherapy-refractory hepatosplenic gammadelta T-cell lymphoma: case report and review of the literature.
    Domm JA; Thompson M; Kuttesch JF; Acra S; Frangoul H
    J Pediatr Hematol Oncol; 2005 Nov; 27(11):607-10. PubMed ID: 16282893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatosplenic gamma-delta T-cell lymphoma.
    Ferreri AJ; Govi S; Pileri SA
    Crit Rev Oncol Hematol; 2012 Aug; 83(2):283-92. PubMed ID: 22047938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatosplenic gammadelta T-cell lymphoma in a 10-year-old boy successfully treated with hematopoietic stem cell transplantation.
    Gassas A; Kirby M; Weitzman S; Ngan B; Abla O; Doyle JJ
    Am J Hematol; 2004 Feb; 75(2):113-4. PubMed ID: 14755380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatosplenic gammadelta T-cell lymphoma successfully treated with a combination of alemtuzumab and cladribine.
    Jaeger G; Bauer F; Brezinschek R; Beham-Schmid C; Mannhalter C; Neumeister P
    Ann Oncol; 2008 May; 19(5):1025-6. PubMed ID: 18375525
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatosplenic alphabeta T-cell lymphoma: an unusual case with clinical, histologic, and cytogenetic features of gammadelta hepatosplenic T-cell lymphoma.
    Suarez F; Wlodarska I; Rigal-Huguet F; Mempel M; Martin-Garcia N; Farcet JP; Delsol G; Gaulard P
    Am J Surg Pathol; 2000 Jul; 24(7):1027-32. PubMed ID: 10895827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatosplenic gammadelta T-cell lymphoma.
    Wei SZ; Liu TH; Wang DT; Cao JL; Luo YF; Liang ZY
    World J Gastroenterol; 2005 Jun; 11(24):3729-34. PubMed ID: 15968729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatosplenic gammadelta T-cell lymphoma presenting with immune-mediated thrombocytopenia and hemolytic anemia (Evans' syndrome).
    Motta G; Vianello F; Menin C; De Nicolo A; Agata S; Altavilla G; Pietrogrande F; Girolami A
    Am J Hematol; 2002 Apr; 69(4):272-6. PubMed ID: 11921021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Factors of Hepatosplenic T-cell Lymphoma: Clinicopathologic Study of 28 Cases.
    Yabe M; Medeiros LJ; Tang G; Wang SA; Ahmed S; Nieto Y; Hu S; Bhagat G; Oki Y; Patel KP; Routbort M; Luthra R; Fanale MA; Bueso-Ramos CE; Jorgensen JL; Vega F; Chen W; Hoehn D; Konoplev S; Milton DR; Wistuba I; Li S; You MJ; Young KH; Miranda RN
    Am J Surg Pathol; 2016 May; 40(5):676-88. PubMed ID: 26872013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatosplenic gamma/delta T-cell lymphoma in bone marrow. A sinusoidal neoplasm with blastic cytologic features.
    Vega F; Medeiros LJ; Bueso-Ramos C; Jones D; Lai R; Luthra R; Abruzzo LV
    Am J Clin Pathol; 2001 Sep; 116(3):410-9. PubMed ID: 11554170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatosplenic γδ T-cell lymphoma: an overview.
    Visnyei K; Grossbard ML; Shapira I
    Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):360-9. PubMed ID: 23876844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rare cause of Fever, hepatosplenomegaly, and thrombocytopenia: hepatosplenic gamma/delta T-cell lymphoma.
    Albayrak M; Balcik OS; Alan S; Dıncer SL; Yüksel MK; Albayrak A
    Pathol Oncol Res; 2011 Jun; 17(2):421-3. PubMed ID: 21197592
    [No Abstract]   [Full Text] [Related]  

  • 19. Persistent non-neoplastic gammadelta-T cells in cerebrospinal fluid of a patient with hepatosplenic (gammadelta) T cell lymphoma: a case report with 6 years of flow cytometry follow-up.
    Jiang L; Abati AD; Wilson W; Stetler-Stevenson M; Yuan C
    Int J Clin Exp Pathol; 2009 Oct; 3(1):110-6. PubMed ID: 19918335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rare variety of T-cell lymphoma.
    Pednekar S; Morge V; Rawal S; Korivi D; Ramteke V; Naik K
    J Assoc Physicians India; 2011 Oct; 59():667-8. PubMed ID: 22479752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.